STOUGHTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present nine posters showcasing real-world data from its differentiated pain ...

AVENTURA, Fla.--(BUSINESS WIRE)--Immersion Corporation (“Immersion”, the “Company”, “we”, “us” or “our”) (Nasdaq: IMMR), a leading provider of ...

LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel ...

SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15, 2025 it granted stock options to purchase an aggregate of 105 ...

SALT LAKE CITY, Aug. 19, 2025 (GLOBE NEWSWIRE) -- OMNIQ Corp. (OTCMKTS:OMQS) or “The Company” announced today the financial results of the second quarter 2025, showing a strong financial turnaround in ...

During the second quarter of 2025, we generated a net loss of $8.3 million or $0.20 per share compared to net income of $0.6 million or $0.02 per share in the previous quarter, and net loss of $9.7 ...